(Continuation news of ACTIVEFINE): under the caption "National Active Pharmaceutical Ingredients (API) & Laboratory Reagents Production and Export Policy" regarding tax exemption against which SRO from National Board of Revenue (NBR) is yet to be obtained. Moreover, the company has provided prior year excess tax Tk. 102,093,375 in the statement of changes in equity for the year ended June 30, 2019 which is not in line with para 4 of IAS 8, para 46, 80(b), (cont.2)